
Cardio-oncology lives at the juntion between two fast-moving fields. Cancer treatment keeps improving, patients live longer, and more of those patients carry cardiovascular risk that has to be managed alongside their oncology care. That much is not…

I recently attended ESC Cardio-Oncology 2026 in Vienna. Alongside other major international gatherings like Global Cardio-Oncology Summit, the ESC Cardio-Oncology Conference remains a vital forum for experts at the intersection of cardiology and cancer care. This trip wasn’t just…

The moderate aortic stenosis risk score is a new clinical tool designed to predict who is truly at risk of cardiac death or heart failure hospitalisation — and who is likely to do well. If you have…